
About Nextec Lifesciences Private Limited
Data last updated:
Nextec Lifesciences Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 17 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2012PTC051518.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ranjana Srivastava and Brahm Shanker Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2/79 Vijaykhand Gomtinagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2025, the company reported a revenue of ₹38,610, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹1.86 Lakh (net margin -482.1%) and EBITDA of -₹1.86 Lakh (EBITDA margin -480.8%). Revenue has declined at a compounded annual rate (CAGR) of 32% over three years and 11% over five years.
The company is associated with 2 brands: Nextec Life Sciences and Nextec Lifesciences.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nexteclifesciences.in.
Company details
Contact details
Nextec Lifesciences Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is nexteclifesciences.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2/79 Vijaykhand Gomtinagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Nextec Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nextec Lifesciences operates two associated brands: Nextec Life Sciences and Nextec Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides a DNA-based kit for early diagnosis of tuberculosis to improve health outcomes. | nexteclifesciences.com | |
| Diagnostic solutions and vaccines for infectious diseases are developed. | nexteclifesciences.in |
Financials of Nextec Lifesciences Private Limited
FY 2025 filings availableNextec Lifesciences Private Limited reported revenue of ₹38,610 (down 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 68% fall in the latest year. EBITDA fell 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -480.8% | ||||
| Net Profit Margin | -482.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nextec Lifesciences Private Limited, buy the company report.
Board of directors of Nextec Lifesciences Private Limited
Nextec Lifesciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjana Srivastava | Director | 17 Jul 2012 | 14 Years 4 Months | Current |
| Brahm Shanker Srivastava | Director | 17 Jul 2012 | 14 Years 4 Months | Current |
Peer comparison
Nextec Lifesciences Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Lifesciences), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panchasutra Lifesciences Private Limited | ₹45,057 (FY 2019) | Udupi, Karnataka, India | ||||
| Kedwin Lifesciences Private Limited | ₹44,984 (FY 2025) | Panchkula, Haryana, India | ||||
| Neutro Lifesciences Private Limited | ₹43,040 (FY 2024) | -64.0% | Pune, Maharashtra, India | |||
| Stotra Lifesciences Private Limited | ₹40,500 (FY 2025) | 65.0% | Hyderabad, Telangana, India | |||
| Biobab Lifesciences Private Limited | ₹40,000 (FY 2025) | Cuttack, Odisha, India | ||||
| Nextec Lifesciences Private Limitedthis company | ₹38,610 (FY 2025) | -₹1.86 Lakh | -482.1% | -68.0% | Lucknow, Uttar Pradesh, India | |
| Tureis Lifesciences Private Limited | ₹38,050 (FY 2025) | -97.0% | Varanasi, Uttar Pradesh, India | |||
| Magecon Lifesciences (OPC) Private Limited | ₹37,414 (FY 2019) | Bangalore, Karnataka, India | ||||
| Winstar Lifesciences Private Limited | ₹35,100 (FY 2022) | -82.0% | Jaipur, Rajasthan, India | |||
| Welmen Lifesciences Private Limited | ₹33,839 (FY 2023) | Lucknow, Uttar Pradesh, India | ||||
| Shrydus Lifesciences Private Limited | ₹33,092 (FY 2025) | 661740.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Nextec Lifesciences Private Limited, buy the company report.
Auditor
Nextec Lifesciences Private Limited is audited by JAI ALOK & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAI ALOK & ASSOCIATES | FY 2017 | 004124C |
Shareholding
The shareholding of Nextec Lifesciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nextec Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nextec Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nextec Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nextec Lifesciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nextec Lifesciences Private Limited has 8 board changes on record since 2012: 5 appointments and 3 cessations. The latest: Hemant Sharma ceased to be Director on 20 Oct 2019.
Frequently asked questions
Nextec Lifesciences is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 17 July 2012 (14+ years old) and is registered under CIN U24233UP2012PTC051518.
Nextec Lifesciences has 2 current directors:
- Ranjana Srivastava - Director
- Brahm Shanker Srivastava - Director
The latest financial statements of Nextec Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nextec Lifesciences is U24233UP2012PTC051518. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nextec Lifesciences was incorporated on 17 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Nextec Lifesciences by revenue are Panchasutra Lifesciences Private Limited, Kedwin Lifesciences Private Limited, Neutro Lifesciences Private Limited, Stotra Lifesciences Private Limited, Biobab Lifesciences Private Limited and 5 more, all in the Pharma industry (Lifesciences).
Hemant Sharma ceased to be Director on 20 Oct 2019. Hemant Sharma was appointed as Director on 25 Mar 2019. Deepak Kumar ceased to be Director on 17 Feb 2017. Nextec Lifesciences has 8 board changes on record in total.
Nextec Lifesciences can be reached through the website nexteclifesciences.in. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Nextec Lifesciences is at 279 Vijaykhand Gomtinagar, Lucknow, Uttar Pradesh, India – 226010.
Nextec Lifesciences operates in the chemicals industry, in the manufacturing segment.
The compliance status of Nextec Lifesciences is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.

